1-[4-(5-Hydroxy-pyridin-2-yl)-piperazin-1-yl]-3-methyl-3-phenyl-butan-1-one

ID: ALA5267542

Chembl Id: CHEMBL5267542

Max Phase: Preclinical

Molecular Formula: C20H25N3O2

Molecular Weight: 339.44

Names and Identifiers

Canonical SMILES:  CC(C)(CC(=O)N1CCN(c2ccc(O)cn2)CC1)c1ccccc1

Standard InChI:  InChI=1S/C20H25N3O2/c1-20(2,16-6-4-3-5-7-16)14-19(25)23-12-10-22(11-13-23)18-9-8-17(24)15-21-18/h3-9,15,24H,10-14H2,1-2H3

Standard InChI Key:  QKXKVJJLPPTDJE-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5267542

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 339.44

Molecular Weight (Monoisotopic): 339.1947

AlogP: 2.80

#Rotatable Bonds: 4

Polar Surface Area: 56.67

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 10.07

CX Basic pKa: 6.20

CX LogP: 3.09

CX LogD: 3.07

Aromatic Rings: 2

Heavy Atoms: 25

QED Weighted: 0.93

Np Likeness Score: -1.41

References

1. Sheth G, Shah SR, Sengupta P, Jarag T, Chimanwala S, Sairam KVVM, Jain V, Talwar R, Dhanave A, Raviya M, Menon S, Trivedi S, Chitturi TR..  (2023)  In the Quest for Potent and Selective Malic Enzyme 3 Inhibitors for the Treatment of Pancreatic Ductal Adenocarcinoma.,  14  (1.0): [PMID:36655126] [10.1021/acsmedchemlett.2c00369]

Source

Source(1):

• Scientific Literature